Gary D Clark

Dr. Gary D Clark is a Professor in the Department of Pediatrics-Neurology at Baylor College of Medicine, Houston, Texas. His research focuses on neurogenetic disorders, rare disease diagnostics, and translational genomics. He is actively involved in the Undiagnosed Diseases Network (UDN) and clinical trials evaluating therapies like cannabidiol for epilepsy and neurodegenerative conditions. Key research interests include genomic sequencing applications, telehealth innovations for rare disease evaluation, and health equity in genomic medicine.

Dr. Clark’s work emphasizes leveraging advanced genomic tools to resolve diagnostic challenges in pediatric neurology. He has contributed to studies on transdifferentiation-based RNA sequencing, antisense oligonucleotide therapies, and the long-term efficacy of CBD in neurodevelopmental disorders. His clinical practice integrates cutting-edge genetic analysis with patient-centered care, particularly for complex cases involving multisystem abnormalities.

Collaborations with interdisciplinary teams and global research networks underpin his efforts to bridge gaps in understanding rare disorders. His research also addresses sociocultural barriers to genomic participation and the ethical implications of undiagnosed disease studies.